chevron_leftBack
As of 13 June 2026, CORESTEMCHEMON Inc. has a market cap of $95.09M USD, ranking #25921 globally and #1263 in South Korea.
It ranks #2325 in the Healthcare sector, and #838 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$95.09MUSD
144.61B KRW
Enterprise Value
$114.91MUSD
175.37B KRW
Revenue (TTM)
$13.26MUSD
20.16B KRW
EBITDA (TTM)
-$11.21MUSD
-17.11B KRW
Net Income (TTM)
-$17.64MUSD
-26.83B KRW
EBITDA Margin
-85%
Profit Margin
-133%
PS Ratio
7.2
PB Ratio
2.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Kyung-Suk Kim
open_in_new
Employees
36
Founded
2003
Website
corestem.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 1.6% | 29% | -16% | 80% | -3.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
166480
코아스템켐온 주식회사
ISIN: KR7166480004
Shares Out.:
Shares Outstanding:
48.095M1
Shares Float:
43.387M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3,260 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CORESTEMCHEMON Inc.
CORESTEMCHEMON Inc., a bio-pharmaceutical company, engages in the development and production of stem cell therapies for the treatment of incurable diseases in South Korea. It offers NEURONATA-R inj, an autologous bone marrow mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis (ALS). The company also engages in the development of various therapy products for the treatment of systemic lupus erythematosus (SLE), multiple system atrophy (MSA), and cerebellar ataxia (CA) diseases. The company has a strategic partnership with ATG Lifetech to deliver precision-driven non-clinical solutions to pharmaceutical companies and biotech ventures. The company was formerly known as Corestem, Inc. CORESTEMCHEMON Inc. was founded in 2003 and is based in Seongnam-si, South Korea.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 0126Z0
|
$9.15B
10K%
13.91T KRW
|
-
|
|
KRX: 000250
|
$6.77B
7K%
10.3T KRW
|
1958.1
|
|
KRX: 326030
|
$5.24B
5K%
7.97T KRW
|
29.9
|
|
KRX: 298380
|
$4.96B
5K%
7.55T KRW
|
-
|
|
KRX: 000100
|
$4.55B
5K%
6.92T KRW
|
35.9
|
|
KRX: 141080
|
$4.44B
5K%
6.76T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
801K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
575K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
379K%
|
97.4
|
|
SIX: RO
|
$321.52B
338K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
304K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
289K%
218.9B CHF
|
20.5
|
chevron_leftBack